Director Kim S. Fennebresque filed a Form 4 with the SEC on August 10, 2026, disclosing the sale of 34,138 shares of BlueLinx Holdings Inc. common stock on August 6, 2026, held indirectly through a grantor trust.

Key Highlights

  • Transaction date: 34,138 shares of BlueLinx Holdings Inc. (NYSE: BXC) common stock were disposed of on August 6, 2026, at a weighted average price of $84.15 per share.
  • Price range: According to the filing, the shares were sold at prices ranging from $82.46 to $85.51 per share.
  • Post-transaction indirect ownership: Following the reported sale, the grantor trust held 0 shares of common stock directly attributed to that indirect position.
  • Direct ownership: The reporting person also holds 12,982 shares of common stock directly.
  • Restricted stock units: The filing reports a total of 72,446 restricted stock units across four tranches held indirectly by grantor trust and one tranche held directly, each representing a contingent right to receive one share of BXC common stock.
  • Reporting person role: Kim S. Fennebresque is identified as a Director of BlueLinx Holdings Inc.

Fennebresque Grantor Trust Sale and Remaining BlueLinx Holdings Positions

According to the Form 4 filed on August 10, 2026, Kim S. Fennebresque, a Director of BlueLinx Holdings Inc., reported the sale of 34,138 shares of BXC common stock on August 6, 2026, held indirectly through a grantor trust. The filing states the transaction code was "S" (a sale), with the weighted average price of $84.15 per share. The filing notes that prices ranged from $82.46 to $85.51 per share and that the reporting person "undertakes to provide BXC, any security holder of BXC, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range."

Following the reported sale, the grantor trust's direct position in common stock stands at 0 shares, per the filing. Separately, the reporting person retains a direct beneficial ownership of 12,982 shares of common stock. In addition to common stock, the filing discloses five tranches of restricted stock units (RSUs): 4,266 RSUs held directly (time-based, vesting May 18, 2027); and four tranches held indirectly by grantor trust totaling 68,180 RSUs, with vesting dates ranging from January 11, 2018 through May 21, 2021. Each RSU represents a contingent right to receive one share of BlueLinx Holdings Inc. common stock.

For the already-vested tranches held indirectly, the filing discloses deferred delivery schedules. Shares underlying the grantor trust RSUs will be delivered within 30 days after the earlier of specified dates (ranging from January 11, 2027 to May 21, 2030) or termination of the reporting person's service on the Board of Directors, according to the filing. The Form 4 was signed by Christin Lumpkin as attorney-in-fact for Kim S. Fennebresque.

What Was Disclosed

The filing reports the August 6, 2026 sale of 34,138 BXC common shares held indirectly via grantor trust at a weighted average of $84.15 per share, direct ownership of 12,982 shares, and holdings of 72,446 restricted stock units across five tranches at various vesting and delivery dates.